A Long Non-coding RNA Activated by Transforming Growth Factor-β is an Independent Prognostic Marker of Gastric Cancer

Annals of Surgical Oncology

Volumn 22, Issue , 2015, Pages 915-922

  Saito, Tomoko ^a,b   Kurashige, Junji ^a   Nambara, Sho ^a   Komatsu, Hisateru ^a   Hirata, Hidenari ^a   Ueda, Masami ^a   Sakimura, Shotaro ^a   Uchi, Ryutaro ^a   Takano, Yuki ^a   Shinden, Yoshiaki ^a   Iguchi, Tomohiro ^a   Eguchi, Hidetoshi ^a   Ehata, Shogo ^c   Murakami, Kazunari ^b   Sugimachi, Keishi ^a   Mimori, Koshi ^a  

^a KYUSHU UNIVERSITY BEPPU HOSPITAL   (Japan)

^b OITA UNIVERSITY HOSPITAL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

4 [4 (1,3 BENZODIOXOL 5 YL) 5 (2 PYRIDINYL) 1H IMIDAZOL 2 YL]BENZAMIDE; LONG UNTRANSLATED RNA; MICRORNA 200; MICRORNA 200B; MICRORNA 200C; TRANSCRIPTION FACTOR ZEB1; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN; HOMEODOMAIN PROTEIN; MESSENGER RNA; MICRORNA; MIRN200 MICRORNA, HUMAN; TRANSCRIPTION FACTOR; TUMOR MARKER; ZEB1 PROTEIN, HUMAN;

AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STOMACH CANCER; UPREGULATION; ADENOCARCINOMA; APOPTOSIS; CANCER STAGING; CELL PROLIFERATION; COLLOID CARCINOMA; ENZYME IMMUNOASSAY; FOLLOW UP; GENETICS; LIVER TUMOR; LYMPH NODE METASTASIS; METABOLISM; PATHOLOGY; PERITONEUM TUMOR; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; SECONDARY; SIGNET RING CARCINOMA; STOMACH TUMOR; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; AGED; APOPTOSIS; BIOMARKERS, TUMOR; CARCINOMA, SIGNET RING CELL; CELL PROLIFERATION; FEMALE; FOLLOW-UP STUDIES; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOENZYME TECHNIQUES; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PERITONEAL NEOPLASMS; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, LONG NONCODING; RNA, MESSENGER; STOMACH NEOPLASMS; SURVIVAL RATE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; TUMOR CELLS, CULTURED; ZINC FINGER E-BOX-BINDING HOMEOBOX 1;

EID: 84952876322     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-015-4554-8     Document Type: Article

References (26)

1. Nagini S. Carcinoma of the stomach: a review of epidemiology, pathogenesis, molecular genetics and chemoprevention. World J Gastrointest Oncol. 2012;4:156–69.
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2002;2:442–54.
3. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol. 2003;15:740–6.
4. Gregory PA, Bert AG, Paterson EL, et al. The MiR-200 family and MiR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol. 2008;10:593–601.
5. Wellner U, Schubert J, Burk UC, et al. The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol. 2009;11:1487–95.
6. Yu J, Ohuchida K, Mizumoto K, et al. MicroRNA, Hsa-miR-200c, is an independent prognostic factor in pancreatic cancer and its upregulation inhibits pancreatic cancer invasion but increases cell proliferation. Mol Cancer. 2010;9:169.
7. Hur K, Toiyama Y, Takahashi M, et al. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis. Gut. 2013;62:1315–26.
8. Liu XG, Zhu WY, Huang YY, et al. High expression of serum MiR-21 and tumor MiR-200c associated with poor prognosis in patients with lung cancer. Med Oncol. 2012;29:618–26.
9. Cheng H, Zhang L, Cogdell DE, et al. Circulating plasma MiR-141 is a novel biomarker for metastatic colon cancer and predicts poor prognosis. PLoS One. 2011;6:e17745.
10. Kurashige J, Kamohara H, Watanabe M, et al. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann Surg Oncol. 2012;19 Suppl 3:S656–64.
11. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the MiR-200 family promotes EMT and invasion in cancer cells. EMBO Rep. 2008;9:582–9.
12. Prensner JR, Chinnaiyan AM. The emergence of LncRNAs in cancer biology. Cancer Discov. 2011;1:391–407.
13. Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482:339–46.
14. Tsai MC, Manor O, Wan Y, et al. Long noncoding RNA as modular scaffold of histone modification complexes. Science. 2010;329:689–93.
15. Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464:1071–6.
16. Matouk IJ, DeGroot N, Mezan S, et al. The H19 non-coding rna is essential for human tumor growth. PLoS One. 2007;2:e845.
17. Liu XH, Sun M, Nie FQ, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging MiR-331-3p in gastric cancer. Mol Cancer. 2014;13:92.
18. Shao Y, Chen H, Jiang X, et al. Low expression of LncRNA-HmlincRNA717 in human gastric cancer and its clinical significances. Tumour Biol. 2014;35(10):9591–5.
19. Wang Y, Zhang D, Wu K, Zhao Q, Nie Y, Fan D. Long non-coding RNA MRUL promotes ABCB1 expression in multidrug-resistant gastric cancer cell sublines. Mol Cell Biol. 2014;34:3182–93.
20. Yuan JH, Yang F, Wang F, et al. A long noncoding RNA activated by TGF-beta promotes the invasion-metastasis cascade in hepatocellular carcinoma. Cancer Cell. 2014;25:666–81.
21. Kurokawa Y, Matsuura N, Kawabata R, et al. Prognostic impact of major receptor tyrosine kinase expression in gastric cancer. Ann Surg Oncol. 2014;21 Suppl 4:S584–90.
22. Hashiguchi Y, Nishida N, Mimori K, et al. Down-regulation of MiR-125a-3p in human gastric cancer and its clinicopathological significance. Int J Oncol. 2012;40:1477–82.
23. Tan Z, Jiang H, Wu Y, et al. MiR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol Cell Biochem. 2014;386:223–31.
24. Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell. 2011;22:1686–98.
25. Truong HH, Xiong J, Ghotra VP, et al. Beta1 integrin inhibition elicits a prometastatic switch through the TGFbeta-miR-200-ZEB network in E-cadherin-positive triple-negative breast cancer. Sci Signal. 2014;7:ra15.
26. Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 2014;15:178–96.